Abbott Medical Devices

This study is collecting real-world safety and effectiveness data on a balloon-based heart procedure (the Volt PFA System) used to treat symptomatic atrial fibrillation (AFib). It will enroll 300 adults with AFib who plan to undergo this specific ablation procedure. The main goal…

This study aims to collect long-term safety and effectiveness data on Abbott's deep brain stimulation (DBS) systems. It will follow 1,000 people with movement disorders like Parkinson's disease, essential tremor, or dystonia for five years after their device is implanted. The goa…

This study is testing a new device called the Cephea Mitral Valve System. It is for people with a leaky or narrowed mitral heart valve who are not good candidates for open-heart surgery. Doctors will insert the new valve using a thin tube (catheter) to see if it is safe and can e…

This study is testing a new medical device system designed to treat a common type of irregular heartbeat called atrial fibrillation (AFib). The procedure uses pulsed electrical fields to scar heart tissue and block faulty electrical signals. Researchers aim to see if this new sys…

This study is testing a new device called the Cephea Mitral Valve System for people with a leaky or narrowed mitral valve in their heart. The goal is to see if this less invasive procedure, done through a catheter, is safe and can effectively reduce the severity of the valve prob…

This study is testing whether a surgically implanted brain stimulation device can help adults with severe depression that hasn't improved with multiple medications. Researchers will compare active stimulation to a sham (inactive) treatment in 100 participants over 12 months. The …

This study is testing the safety and performance of two specific heart pacing leads when placed in a particular area of the heart's electrical system. Researchers will follow 200 adult patients for 6 months after implant to check for complications like infection, lead movement, o…

This study is monitoring how well and how safely a new heart valve device works for people in Japan with severe aortic stenosis, a narrowing of a major heart valve. It will follow about 100 patients for one year after their procedure to check for complications and see how the val…

This trial is testing if implanting a mechanical heart pump (HeartMate 3) early can help people with advanced heart failure live longer and have a better quality of life compared to staying on strong medications alone. It will enroll about 850 adults whose heart failure is worsen…

This study is testing a new type of heart stent called AMJ-401 in Japan. The stent is designed to dissolve over time after it props open a blocked heart artery. Researchers will check how safe it is and how well it works by looking at it with special imaging 6 months after placem…

This study is testing a new medical device designed to treat severely hardened and narrowed heart arteries. The device uses sound wave technology (intravascular lithotripsy) to break up hard calcium deposits inside the artery before a stent is placed. Researchers aim to see if th…

This study is testing a new type of pacemaker that is completely wireless and placed inside the heart. It aims to see if the device is safe and works properly for people who need a pacemaker for a slow heart rhythm. Researchers will follow 20 participants for at least a year to c…

This study is monitoring the real-world safety and effectiveness of the Esprit BTK device, a small, dissolving scaffold placed in leg arteries. It aims to improve blood flow in patients with severe leg pain or non-healing wounds caused by blocked arteries below the knee. The goal…

This study is collecting real-world data on how well Abbott's heart repair devices work and how safe they are after they're already approved and being used in hospitals. It will follow about 2,500 patients who receive these devices as part of their standard care for various heart…

This study is testing a new medical device designed to help doctors safely access the left side of the heart during certain heart procedures. It will involve about 20 people who are already scheduled for a specific type of heart procedure. The main goal is to check if the device …

This study is collecting information from 1,000 people with symptomatic mitral valve disease, which involves a leaky or narrowed heart valve. The goal is to track how patients do after receiving a minimally invasive valve replacement procedure. The data will help doctors better u…

This study aims to collect real-world safety and effectiveness data on Abbott's implanted neurostimulation devices for chronic pain. It will follow 2,000 patients for up to five years after they receive the device to track any side effects and how well it works over time. The goa…